Dr. Grant Pierce and Dr. Pavel Dibrov's research was published in the Canadian Journal of Physiology and Pharmacology Thursday. It shows how their newly-developed drug, PEG-2S, cuts off the energy source of bacteria — a protein vital to their survival. Most antibiotics today attack one of three targets — the cell wall, protein synthesis or DNA replication within the bacteria, said Pierce. Researchers at St. Boniface Hospital have developed a new drug that may treat gonorrhea and other infections which share a particular protein. The drug has potential to treat cholera, wound infections, septicemia, and gonorrhea — infections which all use the same sodium transport mechanism or energy source.

Source: CBC News April 20, 2017 10:52 UTC